4570 — Immuno-Biological Laboratories Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapHigh Flyer

Annual balance sheet for Immuno-Biological Laboratories Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	604	508	614	734	826
Net Total Accounts Receivable
Net Total Receivables	199	174	216	190	232
Total Inventory
Total Other Current Assets
Total Current Assets	1,125	1,130	1,165	1,262	1,390
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	127	120	119	136	191
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,838	1,705	1,434	1,619	1,845
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	145	228	252	258	281
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	209	337	356	353	331
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,629	1,368	1,079	1,265	1,514
Total Liabilities & Shareholders' Equity	1,838	1,705	1,434	1,619	1,845
Total Common Shares Outstanding